BioWorld

Nov. 15, 2002

Untraditional Immune Complex Of CD137 Target, Agonistic Antibody Keep Lupus Murine Models Living

Arena, Lilly Ending GPCR Deal Early After Generating Targets

Advisory Panel Unanimously Backs Roche's HCV Therapy

Scynexis, Roche Collaborate To Discover, Develop Drugs

Other News To Note

Celgene Buying Anthrogenesis For $45M, Expanding Portfolio

Celgene Corp. is shelling out $45 million in stock and options to acquire a subsidiary - a placental stem cell recovery company called Anthrogenesis Corp. (BioWorld Today) Read More

Neurocrine Reports Positive Data From First Phase III Insomnia Trial

Today's news in brief

BioWorld

Illustration of SCAN in Parkinson’s vs healthy subcortex

SCAN is core circuit affected in Parkinson’s disease

BioWorld Science

Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...

TL1A is overexpressed in hidradenitis suppurativa

BioWorld Science

Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...

IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

BioWorld Science

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...

Illustration of head with maze that is missing parts

Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke

BioWorld Science

Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...